| Mrs Holly L Kimbrell, CFNP | |
|
513c Brookman Dr, Brookhaven, MS 39601-2326 | |
| (601) 833-3822 | |
| (601) 835-4330 |
| Full Name | Mrs Holly L Kimbrell |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 25 Years |
| Location | 513c Brookman Dr, Brookhaven, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093796328 | NPI | - | NPPES |
| 02675521 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | R860084 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Field Health System | Centreville, MS | Hospital |
| King's Daughters Medical Center-brookhaven | Brookhaven, MS | Hospital |
| Southwest Ms Regional Medical Center | Mccomb, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwest Ms Nephrology, Pllc | 0345203857 | 4 |
News Archive
Sudden Infant Death Syndrome (SIDS) continues to be the third leading cause of infant death, according to the Centers for Disease Control (CDC), despite a decline in SIDS that is associated with a rise in safe-sleep practices for newborns and infants. A new study by Barbara M. Ostfeld, PhD and Thomas Hegyi, MD, professors in the Department of Pediatrics at UMDNJ-Robert Wood Johnson Medical School, has identified that more than 96 percent of infants who died of SIDS were exposed to known risk factors, among them sleeping on their side or stomach, or exposure to tobacco smoke, and that 78 percent of SIDS cases contained multiple risk factors.
Genzyme Corporation announced today that the FDA notified the company yesterday afternoon that, while the agency recognizes Genzyme's efforts, it intends to take enforcement action to ensure that products manufactured at the plant are made in compliance with good manufacturing practice regulations. The FDA enforcement action will likely result in a consent decree, under which a third party would inspect and review the plant's operation for an extended period and certify compliance with FDA regulations.
eDiets.com, Inc. today announced that it has completed its previously announced registered direct offering to select institutional investors for an aggregate of 5,275,000 shares. The shares were priced at $1.00 per share, resulting in total net proceeds of approximately $4.7 million, after deducting placement agent fees and other offering expenses.
Patients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two co-primary endpoints-a composite of rate of death, heart attack or stroke at 30 days, or a composite of those events plus major bleeding-as compared to patients receiving standard anticoagulation therapy, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session.
› Verified 2 days ago
| Entity Name | Southwest Ms Nephrology, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396894234 PECOS PAC ID: 0345203857 Enrollment ID: O20041105000657 |
News Archive
Sudden Infant Death Syndrome (SIDS) continues to be the third leading cause of infant death, according to the Centers for Disease Control (CDC), despite a decline in SIDS that is associated with a rise in safe-sleep practices for newborns and infants. A new study by Barbara M. Ostfeld, PhD and Thomas Hegyi, MD, professors in the Department of Pediatrics at UMDNJ-Robert Wood Johnson Medical School, has identified that more than 96 percent of infants who died of SIDS were exposed to known risk factors, among them sleeping on their side or stomach, or exposure to tobacco smoke, and that 78 percent of SIDS cases contained multiple risk factors.
Genzyme Corporation announced today that the FDA notified the company yesterday afternoon that, while the agency recognizes Genzyme's efforts, it intends to take enforcement action to ensure that products manufactured at the plant are made in compliance with good manufacturing practice regulations. The FDA enforcement action will likely result in a consent decree, under which a third party would inspect and review the plant's operation for an extended period and certify compliance with FDA regulations.
eDiets.com, Inc. today announced that it has completed its previously announced registered direct offering to select institutional investors for an aggregate of 5,275,000 shares. The shares were priced at $1.00 per share, resulting in total net proceeds of approximately $4.7 million, after deducting placement agent fees and other offering expenses.
Patients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two co-primary endpoints-a composite of rate of death, heart attack or stroke at 30 days, or a composite of those events plus major bleeding-as compared to patients receiving standard anticoagulation therapy, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Holly L Kimbrell, CFNP 513c Brookman Dr, Brookhaven, MS 39601-2326 Ph: (601) 833-3822 | Mrs Holly L Kimbrell, CFNP 513c Brookman Dr, Brookhaven, MS 39601-2326 Ph: (601) 833-3822 |
News Archive
Sudden Infant Death Syndrome (SIDS) continues to be the third leading cause of infant death, according to the Centers for Disease Control (CDC), despite a decline in SIDS that is associated with a rise in safe-sleep practices for newborns and infants. A new study by Barbara M. Ostfeld, PhD and Thomas Hegyi, MD, professors in the Department of Pediatrics at UMDNJ-Robert Wood Johnson Medical School, has identified that more than 96 percent of infants who died of SIDS were exposed to known risk factors, among them sleeping on their side or stomach, or exposure to tobacco smoke, and that 78 percent of SIDS cases contained multiple risk factors.
Genzyme Corporation announced today that the FDA notified the company yesterday afternoon that, while the agency recognizes Genzyme's efforts, it intends to take enforcement action to ensure that products manufactured at the plant are made in compliance with good manufacturing practice regulations. The FDA enforcement action will likely result in a consent decree, under which a third party would inspect and review the plant's operation for an extended period and certify compliance with FDA regulations.
eDiets.com, Inc. today announced that it has completed its previously announced registered direct offering to select institutional investors for an aggregate of 5,275,000 shares. The shares were priced at $1.00 per share, resulting in total net proceeds of approximately $4.7 million, after deducting placement agent fees and other offering expenses.
Patients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two co-primary endpoints-a composite of rate of death, heart attack or stroke at 30 days, or a composite of those events plus major bleeding-as compared to patients receiving standard anticoagulation therapy, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session.
› Verified 2 days ago
Miss Montoyae C Leavy, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 747 Industrial Park Rd Ne, Brookhaven, MS 39601 Phone: 601-833-4111 | |
Tonya C Hughey, CFNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 940 Brookway Blvd, Brookhaven, MS 39601 Phone: 601-823-5000 Fax: 601-823-4140 | |
Mrs. Candace Laird Duckworth, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1578 Shanna Ln Nw, Brookhaven, MS 39601 Phone: 601-757-9659 | |
Sally M Proffitt, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1024 D A Biglane Dr, Brookhaven, MS 39601 Phone: 601-823-8000 | |
Marty Kyle Ballard Sr., FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 327 N Jackson St, Brookhaven, MS 39601 Phone: 601-833-3800 Fax: 601-833-3847 | |
Jennifer D Smith, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1005 W Congress St, Brookhaven, MS 39601 Phone: 601-833-9388 Fax: 601-833-9495 | |
Miss Brittany Griffin Mullins, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 201 Highway 51 N Ste A, Brookhaven, MS 39601 Phone: 601-833-5333 |